Verastem Oncology Receives Fast-Track Designation for Avutometinib and Sotorasib Combination in NSCLC
1 Mins read
Boston-based biopharmaceutical company, Verastem Oncology, has announced that the US Food and Drug Administration (FDA) has granted their avutometinib and sotorasib combination…